Skip to Main Content

SPS PGD template for the supply and/or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection for contraception.

Provenance

Written by SPS and the College of Sexual and Reproductive Healthcare (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice.

More reproductive health PGD templates

All PGD templates

National PGD, protocol and written instructions templates

National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.

Update history

  1. Republished
  2. Expired PGD template removed
  1. Revised template to reflect minor clarifications following feedback.
  1. Version 3.0 published
  1. Planned review detail added
  1. Information added regarding name change of FSRH to CoSRH
  1. Version 2.3 PGD template added. Updated contraindications and cautions in line with SmPC changes.
  1. Updated PGD template published - statement added regarding a suggested link between the prolonged use of medroxyprogesterone acetate and a small increased risk of intracranial meningioma in line with FSRH statement. Added exclusion of meningioma as per SPC.
  1. Version 2.1 published - minor changes to align with updated FSRH guidance
  1. Title, URL and summary amended.
  2. Expiring template removed.
  1. Version 2.0 PGD template added
  1. Published